Partners
Who are we?
Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy.
​
Lung Cancer Canada’s mission aims to:
-
To increase public awareness of lung cancer
-
To support and advocate for lung cancer patients and their families
-
To provide educational resources to patients, family members, healthcare professionals, and the
general public
-
Support promising research opportunities in lung cancer
The Lung Ambition Alliance is a partnership of patient organizations, scientific and medical societies,
and industry committed to tackling barriers to ultimately eliminate lung cancer as a cause of death.
The Lung Ambition Alliance aims to double 5-Year Survival in Lung Cancer.
​
Goal: Support initiatives that are aligned to the Lung Ambition strategy and will have meaningful impact on patient outcomes:
-
Screen & diagnose early
-
Enhance the quality of care
-
Improve patient outcomes
Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy.
​
-
Lung Cancer Canada’s mission aims to:
-
To increase public awareness of lung cancer
-
To support and advocate for lung cancer patients and their families
-
To provide educational resources to patients, family members, healthcare professionals, and the
general public
-
Support promising research opportunities in lung cancer
About the partners
-
Lung Cancer Canada is a registered national charity that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy. Based in Toronto, Ontario, Lung Cancer Canada has a wide reach that includes both regional and pan-Canadian initiatives. Lung Cancer Canada is a member of the Global Lung Cancer Coalition and is the only national organization in Canada focused exclusively on lung cancer.
-
AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of medicines that transform lives. AstraZeneca’s core areas of scientific focus are Cardiovascular, Renal and Metabolic (CVRM) disease; Oncology; Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies.
-
The Lung Ambition Alliance is a global coalition, with cross-discipline partners in more than 50 countries dedicated to accelerating innovation and driving meaningful improvements for people with lung cancer. With the bold ambition to one day eliminate cancer as a cause of death, the Alliance is focused on three core areas: increasing screening & diagnosis; delivering innovative medicine; and enhancing the quality of care for lung cancer patients.